Track topics on Twitter Track topics that are important to you
A single-tablet dolutegravir-based combination regimen given daily is noninferior to a multi-pill atazanavir-based regimen in previously untreated women with HIV infection, and has a similar safety profile.
Reuters Health Information
Original Article: Single-Tablet Dolutegravir-Based Therapy for HIV-infected WomenNEXT ARTICLE
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...